Jurisdiction

Germany

Germany operates one of Europe's largest and most structured health systems, with regulation spread across several federal bodies. BfArM authorises and monitors medicines and medical devices, the Paul-Ehrlich-Institut oversees vaccines and biomedicines, the Gemeinsame Bundesausschuss (G-BA) sets reimbursement and benefit rules, and BfArM also runs the DiGA fast-track for reimbursable digital health applications. This page collects the German regulatory updates HealthSignal tracks across these bodies, from official public sources only.

Regulation Category Type · Breadth Date

BfArM: News from the divisions

New information and updates on our website. New information in the topic medicinal products New information in the topic licensing New information in the topic clinical trials New information in the topic Pharmacovigi...

BfArM (Federal Institute for Drugs) · Germany
General Regulatory
Administrative Framework

BfArM Blog Archive

Until 2024, the “BfArM4Health” blog provided insights intoBfArM’s work and key developments in healthcare. Experts introduced their areas of responsibility and presented selected projects.

BfArM (Federal Institute for Drugs) · Germany
General Regulatory
Administrative Framework

BfArM 30th Anniversary (1994–2024)

We move forward - since 1994! In 2024 the Federal Institute for Drugs and Medical Devices (BfArM) celebrated its 30th anniversary. Since 1994, the agency is working to ensure the efficacy and safety of medicinal produ...

BfArM (Federal Institute for Drugs) · Germany
General Regulatory
News & press Framework

BfArM Publications

The publications of the Federal Institute for Drugs and Medical Devices offer a further source of information. Annual reports of the Federal Institute for Drugs and Medical Devices

BfArM (Federal Institute for Drugs) · Germany
General Regulatory
Administrative Framework
Showing 16 of 16 tracked updates Health-tech only See all in the feed